Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.
复制标题
DOI:
10.1038/s41467-023-36907-0
复制
发表时间:
2023-03-07
影响因子:
16.6
通讯作者:
Mattapallil, Joseph J.
中科院分区:
文献类型:
--
作者:
Mattathil, Jeffy G.;Volz, Asisa;Onabajo, Olusegun O.;Maynard, Sean;Bixler, Sandra L.;Shen, Xiaoying X.;Vargas-Inchaustegui, Diego;Robert-Guroff, Marjorie;Lebranche, Celia;Tomaras, Georgia;Montefiori, David;Sutter, Gerd;Mattapallil, Joseph J.
Human immunodeficiency virus (HIV) is a mucosally transmitted virus that causes immunodeficiency and AIDS. Developing efficacious vaccines to prevent infection is essential to control the epidemic. Protecting the vaginal and rectal mucosa, the primary routes of HIV entry has been a challenge given the significant compartmentalization between the mucosal and peripheral immune systems. We hypothesized that direct intranodal vaccination of mucosa associated lymphoid tissue (MALT) such as the readily accessible palatine tonsils could overcome this compartmentalization. Here we show that rhesus macaques primed with plasmid DNA encoding SIVmac251-env and gag genes followed by an intranodal tonsil MALT boost with MVA encoding the same genes protects from a repeated low dose intrarectal challenge with highly pathogenic SIVmac251; 43% (3/7) of vaccinated macaques remained uninfected after 9 challenges as compared to the unvaccinated control (0/6) animals. One vaccinated animal remained free of infection even after 22 challenges. Vaccination was associated with a ~2 log decrease in acute viremia that inversely correlated with anamnestic immune responses. Our results suggest that a combination of systemic and intranodal tonsil MALT vaccination could induce robust adaptive and innate immune responses leading to protection from mucosal infection with highly pathogenic HIV and rapidly control viral breakthroughs. Mucosal surfaces are a primary route of HIV entry, yet the compartmentalisation between mucosal and peripheral immune systems remain a challenge for HIV vaccine candidates. Authors utilise a combination of intranodal tonsil MALT and systemic vaccination in the rhesus macaque model to explore immune responses and protection from highly pathogenic simian homologue of HIV.
登录
查看更多内容
影响因子:
7.3
作者:
Velarde de la Cruz E;Wang L;Bose D;Gangadhara S;Wilson RL;Amara RR;Kozlowski PA;Aldovini A
通讯作者:
Aldovini A
影响因子:
7.2
作者:
Bol KF;Figdor CG;Aarntzen EH;Welzen ME;van Rossum MM;Blokx WA;van de Rakt MW;Scharenborg NM;de Boer AJ;Pots JM;Olde Nordkamp MA;van Oorschot TG;Mus RD;Croockewit SA;Jacobs JF;Schuler G;Neyns B;Austyn JM;Punt CJ;Schreibelt G;de Vries IJ
通讯作者:
de Vries IJ
影响因子:
3.7
作者:
Harmon TM;Fisher KA;McGlynn MG;Stover J;Warren MJ;Teng Y;Näveke A
通讯作者:
Näveke A
影响因子:
4.6
作者:
George J;Valiant WG;Mattapallil MJ;Walker M;Huang YS;Vanlandingham DL;Misamore J;Greenhouse J;Weiss DE;Verthelyi D;Higgs S;Andersen H;Lewis MG;Mattapallil JJ
通讯作者:
Mattapallil JJ
影响因子:
3.7
作者:
Gasper MA;Biswas SP;Fisher BS;Ehnert SC;Sherman DR;Sodora DL
通讯作者:
Sodora DL